03 Aug 2026 RSV Immunizations Now Available
Nirsevimab-alip (Beyfortus) and clesrovimab-cfor (Enflonsia) ordering is now open for the 2026-2027 season.
Beyfortus and Enflonsia are monoclonal antibody immunizations used to prevent RSV infection in infants and young children that can be administered beginning on October 1, 2026. Order a 4-6-week supply now to ensure you have doses on hand when vaccine administration begins in October. The CDC will release RSV immunizations through the Vaccines for Children (VFC) program in monthly allotments, so it is important that sites order now to ensure distribution throughout the city.
Want to order Enflonsia (clesrovimab-cfor) this season? Complete the product change form below to update your RSV product.
Contact the Philadelphia Immunization Program ordering team at dphproviderhelp@phila.gov with any questions.